CLINICAL / ANATOMIC PATHOLOGY / CRO LABORATORIES
CLIA, COLA, CAP-accredited clinical lab in Midwest for Sale. Unique Revenue Model, Consistent Revenue, Exceptional EBITDA Margins. Revenue: $3.4M, EBITDA: $1.4M
This almost brand new NJ Lab is set up as a high throughput lab for Molecular, Covid, and NGS testing. Revenue (10 months): $2.1M, net $1.7M, Price: $2.75M.
Brand New Clinical Laboratory in CO For Sale. New equipment validated for Covid and PGx. CO and CA licenses. Price: $325K. Includes equipment and Inventory worth $500K.
Profitable, fast-growing Lab in Texas. Mostly non-covid testing. Revenue / EBITDA: $5.7M/690K (2022); $8.2M/$1M+ (2023).
The lab has a diversified Revenue Stream from Toxicology, Women’s Health, UTI, Covid, and Respiratory Panel Testing. The lab is well-positioned to continue to grow post-Covid. 2021 Revenue: $6.8M, EBITDA: $2.6M.
Sold Clinical and Pathology Labs
This turn-key lab comes with a great location, excellent growth potential with marketing, and hard-to-get licenses of NY, NJ, and PA in favorable MAC. Had Medicare, Medicaid, and Multiplan. Price $2.2 million
SOLD: The CRO Lab is one of the Early Adapters in Next Generation Sequences and deep expertise in research and applications Biomarkers, Disease Diagnostics and Treatment Development, using RNA, mRNA and microRNA arrays.
Very profitable, successful, and fast-growing anatomical lab in the North East. Known for its high level of service. Revenue; $4-5MM; EBITDA: $1.5-$2MM
SOLD: Profitable Clinical Lab in the Mountain States. Has important network contracts. Gross Revenue: $480K; SDE: $180K; Asking Price: $900K. Includes Aetna, BC, Cigna, Medicare.
SOLD: NY CLIA license. This Clinical lab does Endocrinology / Fertility testing and comes with clean CLIA and NY state licenses. The corporation is only two years old.
SOLD: Tech-2461: Turn-key, High-Capacity, Clinical and Toxicology Labs with two Clean CLIAs in Texas
A rare opportunity to acquire two adjacent CLIA labs - Both Labs have Licenses for 38 states. Comes with completely paid off newer equipment which were bought for $2.7M. Asking price $1.1M. Includes,...
SOLD Tech-2243: DNA Paternity Testing, Forensic Testing Lab in South East. Gross Income (2012): $288K, Discretionary Cash Flow: $134K, assets: $125K.
SOLD Tech-1510: Clinical Diagnostic Lab in Central Philadelphia. One Year Old, CLIA-Approved, Ideal Turn-key Business Opportunity for a Large Physician’s Group. Potential Annual Revenue and Net Profit: $3M and $1M.
SOLD: Tech-1503: CLIA-Certified Profitable Clinical Lab with High Growth Potential in SE USA. Revenue $1.9 million, EBITDA $264K, asset value ~688K.